摘要
背景:阿尔茨海默病(AD)是最常见的与年龄有关的神经退行性疾病。它代表了所有痴呆的70%。全世界有数百万人受到广告的影响。它是一种复杂的疾病,其特征是淀粉样蛋白聚集物和神经原纤维缠结含有高度磷酸化的神经元tau蛋白。 AD需要能够规避血脑屏障(BBB)的药物,BBB不是血脑间简单的物理屏障,而是作为铁幕,只允许选择性分子进入大脑。不幸的是,这种动态屏障限制了药物向大脑的转运;由此,目前很少有药物可用于AD治疗。 目的:本研究主要集中在中枢神经系统旁路给BBB治疗AD的药物治疗策略。 结果:许多研究证明,通过使用不同的策略,有效地克服BBB和将药物靶向CNS。在这里我们已经讨论了一些最重要的药物渗透性和药物靶向方法。 结论:总而言之,仅仅关注药物开发项目的开发是不够的,但是在AD患者的中枢神经系统更为具体和有效的药物发现和给药系统之间保持平衡是非常重要的。
关键词: 阿尔茨海默病,血脑屏障,脑药物递送,药物渗透性,中枢神经系统,AD治疗。
图形摘要
Current Drug Targets
Title:The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview
Volume: 19 Issue: 2
关键词: 阿尔茨海默病,血脑屏障,脑药物递送,药物渗透性,中枢神经系统,AD治疗。
摘要: Background: Alzheimer's disease (AD) is the most frequent age related neurodegenerative disorder. It represents 70% of all dementia. Millions of people have been affected by AD worldwide. It is a complex illness characterized pathologically by accumulation of protein aggregates of amyloid and neurofibrillary tangles containing hyperphosphorylated neuronal tau protein. AD requires drugs that can circumvent the blood–brain barrier (BBB) which is not a simple physical barrier between blood and brain, but acts as an iron curtain, allowing only selective molecules to enter the brain. Unfortunately, this dynamic barrier restricts transport of drugs to the brain; due to which, currently very few drugs are available for AD treatment.
Objective: The present review focuses mainly on strategies used for administration of drug to the CNS by-passing BBB for the treatment of AD.
Results: Many studies have proved to be effective in overcoming BBB and targeting drugs to CNS by using different strategies. Here we have discussed some of the most important drug permeability and drug targeting approaches.
Conclusion: In conclusion, concentrating solely in development of drug discovery programs is not enough but it is important to maintain balance between the drug discovery and drug delivery systems that are more specific and effective in targeting CNS of AD patients.
Export Options
About this article
Cite this article as:
The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview, Current Drug Targets 2018; 19 (2) . https://dx.doi.org/10.2174/1389450118666170612100750
DOI https://dx.doi.org/10.2174/1389450118666170612100750 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot topic: A Multi-Targeted Approach for a Complex Multifaceted Disease (Guest Editors: D.W. Shineman and H.M. Fillit)]
Current Alzheimer Research Stroke Prevention: From Available Antiplatelet Drugs to Novel Molecular Targets
Current Drug Targets Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies Biotechnological Engineering of Heparin/Heparan Sulphate: A Novel Area of Multi-Target Drug Discovery
Current Pharmaceutical Design Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs
Current Medicinal Chemistry Blue-Enriched Lighting for Older People Living in Care Homes: Effect on Activity, Actigraphic Sleep, Mood and Alertness
Current Alzheimer Research Stem Cell Therapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Treatment of Periodontitis for the Prevention of Endothelial Dysfunction: A Narrative Review
Current Vascular Pharmacology Centralized and Local Color Doppler Ultrasound Reading Agreement for Diagnosis of the Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis
Current Neurovascular Research Clinical Applications of Positron Emission Tomography (PET) Imaging in Medicine: Oncology, Brain Diseases and Cardiology
Current Radiopharmaceuticals Subject Index To Volume 8
Protein & Peptide Letters Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
Current Topics in Medicinal Chemistry Clozapine Safety, 40 Years Later
Current Drug Safety Association of Mean Platelet Volume with Hypertension in Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Oxidative Damage Impact on Aging and Age-Related Diseases: Drug Targeting of Telomere Attrition and Dynamic Telomerase Activity Flirting with Imidazole-Containing Dipeptides
Recent Patents on Drug Delivery & Formulation Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Statins, Risk of Death and Ischemic Stroke in Patients with Dementia: A Registry-Based Observational Cohort Study
Current Alzheimer Research Pharmacogenomics – Implications in the Development of HIV-Associated Brain Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry